Novel Therapeutic Targets in Axial Spondyloarthritis

PURPOSE OF REVIEW: Axial spondyloarthritis remains an area of significant unmet clinical need with only two immune pathways currently targeted by licenced therapies compared to other immune-mediated inflammatory joint disorders such as rheumatoid arthritis where a multitude of therapeutic options ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Worth, Claudia, Bowness, Paul, Hussein Al-Mossawi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Seronegative Arthritis (N Haroon, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978800/
https://www.ncbi.nlm.nih.gov/pubmed/29938195
http://dx.doi.org/10.1007/s40674-018-0095-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978800/
https://www.ncbi.nlm.nih.gov/pubmed/29938195
http://dx.doi.org/10.1007/s40674-018-0095-1

Ejemplares similares